about
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesAn Agent-Based Model of a Hepatic Inflammatory Response to Salmonella: A Computational Study under a Large Set of Experimental DataThe apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats.α7-cholinergic receptor mediates vagal induction of splenic norepinephrine.JAK2 inhibition prevents innate immune responses and rescues animals from sepsis.Unphosphorylated STAT3 modulates alpha 7 nicotinic receptor signaling and cytokine production in sepsis.In Silico Augmentation of the Drug Development Pipeline: Examples from the study of Acute Inflammation.Effects of a potent peroxynitrite decomposition catalyst in murine models of endotoxemia and sepsis.Cholinergic regulatory lymphocytes re-establish neuromodulation of innate immune responses in sepsisTerazosin activates Pgk1 and Hsp90 to promote stress resistanceβ2-Adrenoreceptors of regulatory lymphocytes are essential for vagal neuromodulation of the innate immune system.On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death.Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killingMilk fat globule epidermal growth factor-factor 8-derived peptide attenuates organ injury and improves survival in sepsisDifferential alterations of tissue T-cell subsets after sepsis.Virtual Screening against Phosphoglycerate Kinase 1 in Quest of Novel Apoptosis Inhibitors.Nitrosative protein oxidation is modulated during early endotoxemia.Neuroimmune perspectives in sepsis.Chemotherapy-related changes in central nervous system phospholipids and neurocognitive function in childhood acute lymphoblastic leukemia.Dopamine mediates vagal modulation of the immune system by electroacupuncture.Rational design of peptide derivatives for inhibition of MyD88-mediated toll-like receptor signaling in human peripheral blood mononuclear cells and epithelial cells exposed to Francisella tularensis.Neutrophil derived microparticles increase mortality and the counter-inflammatory response in a murine model of sepsis.Role of the transient receptor potential vanilloid 1 in inflammation and sepsisRole of edaravone in managemant of septic peritonitis.Mathematical Model of Innate and Adaptive Immunity of Sepsis: A Modeling and Simulation Study of Infectious Disease.Anti-transforming growth factor β-induced protein antibody ameliorates vascular barrier dysfunction and improves survival in sepsis.Dendritic Cells in Sepsis: Pathological Alterations and Therapeutic Implications.Protective effect of recombinant human brain natriuretic peptide on acute renal injury induced by endotoxin in canines.PYR-41, A Ubiquitin-Activating Enzyme E1 Inhibitor, Attenuates Lung Injury in Sepsis.Macrophage P2X4 receptors augment bacterial killing and protect against sepsis.
P2860
Q24289511-EDED0206-4312-49AA-9060-C2C3EBEFB9E6Q30000073-2A4F8828-4C3B-4549-800F-C65A72A6BBD4Q34053131-0A0BD119-0DFA-4986-A227-22AC7D472967Q34872582-4206A829-2D37-4F42-BDFD-937D4A56C867Q34874129-4745F385-CFBE-4002-A12E-DA74A9EE9E14Q34905862-6ADA6C3C-E61D-4AF2-871D-9DC26DCC4E39Q34908616-8CE2183E-D637-4345-AAFE-EE5729F52217Q34987898-7689E14F-6776-4C39-BA19-D849CED140D3Q35091478-098C3534-540B-47E6-8E96-0AEDE1464ED5Q35545874-8570D3E8-D256-4BE2-8314-811107093715Q35609622-1C2C751D-02B4-4D15-B741-AB510A2B461AQ35765830-662F0375-D84E-41D5-8D7F-D48542D356F2Q35998001-DF28E1B8-2604-4A40-80FC-B1BE38668A6AQ36220249-F4089850-458A-43AD-AA4C-8E2CCA9414E7Q36259440-F8314745-36A2-4D97-9062-90D5B72F4BE4Q36411105-A65C3963-0AC8-4B87-8CDF-9DFCBBC33CBDQ36693997-E91E05BD-B502-46A0-96E2-03B5757F7375Q37210076-F5B60318-3AA9-4EBE-BCD8-4DE2CB883AFAQ37352921-09A8C3C6-9EAF-4478-B8AB-51074198022BQ37629454-A148F045-8801-49FD-9F6D-34C6E99BBC36Q38430661-3E2FF03F-14B2-407C-A75D-23315AE5BB47Q39008991-F0FE0EBF-70E1-4C54-B430-85683C113B7FQ39181423-78008212-800E-40E4-80BE-F0C588FAA7C8Q39928442-E7C24B92-28BA-4D66-9E74-CE10B8A63B1FQ40962051-45F8C428-B127-42C5-9466-30314684AF5FQ41740191-1FBEE9B5-DF3B-4254-B86D-4D1205AE0599Q42717913-8DBE6794-21A2-43F6-B706-2F67DDD5F5A6Q48708935-0A2B51A3-5273-4337-9855-DEFEA0F7B300Q48737658-6E37AC76-9E93-4B12-AB08-5272ADD95790Q55381414-E0DEDB32-5E63-4C9A-8407-8EBA610DA281
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Scientific and clinical challenges in sepsis.
@ast
Scientific and clinical challenges in sepsis.
@en
Scientific and clinical challenges in sepsis.
@nl
type
label
Scientific and clinical challenges in sepsis.
@ast
Scientific and clinical challenges in sepsis.
@en
Scientific and clinical challenges in sepsis.
@nl
prefLabel
Scientific and clinical challenges in sepsis.
@ast
Scientific and clinical challenges in sepsis.
@en
Scientific and clinical challenges in sepsis.
@nl
P2093
P2860
P1476
Scientific and clinical challenges in sepsis.
@en
P2093
Laura Ramos
Luis Ulloa
Michael Brunner
P2860
P304
P356
10.2174/138161209788453248
P577
2009-01-01T00:00:00Z